Founded in 2010, Biomeostasis is a leading Preclinical CRO that offers in vivo research services in the fields of Metabolic, GastroIntestinal & Muscle-Wasting Diseases. For over 15 years, we have been assessing the Efficacy & Mechanisms of action of Health Products that address conditions such as Obesity, Diabetes, MASLD/MASH, Atherosclerosis, Binge-eating, IBD, Sarcopenia, Cachexia, Duchenne Muscular Dystrophy (DMD)... Complementary to our in vivo pharmacology services, we offer Histology and Omics enabling deciphering the efficacy and MoA of Health Products in the metabolic, GI and muscle-wasting spaces. Localisation : Marseille - France
Looking for a particular Biomeostasis employee's phone or email?
The Biomeostasis annual revenue was $4 million in 2026.
Bruno Bariohay is the Co-Founder and CEO of Biomeostasis.
6 people are employed at Biomeostasis.
Biomeostasis is based in Marseille, Provence-Alpes-Côte d'Azur.
The NAICS codes for Biomeostasis are [5417, 541, 54, 54171, 541713].
The SIC codes for Biomeostasis are [87, 873].